Capital Markets Summer 2020

I

Biotechnology Obscurity → Spotlight Lasting Change

I • The world is now focused on biotechnology as a key driver of better health care solutions ‒ COVID-19 genome sequenced in less than two weeks vs. five months for SARS

‒ Researchers fully designed a vaccine only hours after receiving the genetic code

‒ Human studies three months after publication of the genome vs. 20 months for SARS

II

As The Cost to Sequence A Genome Has Declined

The Speed And Efficacy of Treatment Has Accelerated

III

$9,047,003

20

$16,712

IV

11.4

$4,211

$942

4.5

3.6

3.1

V

Months To Clinical Trial

Cost Per Human Genome

2007

2011

2015

2019

SARS (2003)

Influenza A/Indonesia (2006)

Influenza A/ California (2009)

Zika virus (2016)

COVID-19 coronavirus (2019)

VI

Source: National Human Genome Research Institute, Biotechnology Innovation Organization, and Statista estimates.

10